Case Study on Moderna Published by Harvard Business School:
— Brook Jackson 💜 (@IamBrookJackson) January 22, 2023
"The level of reckless disregard for product safety, rational drug design, rigorous testing and quality control in biologics manufacturing is astounding." – Sasha Latypova https://t.co/No4l9lwTyt
Even “FEDS” are screwing THE FEDS
https://www.msn.com/en-us/money/retirement/after-34-years-of-work-for-feds-naperville-man-shorted-on-his-pension/ar-AA16...